LONG COVID19
Clinical trials for LONG COVID19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID19 trials appear
Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to get long COVID sufferers moving again
Symptom relief OngoingThis study looks at different treatments to help people with Long COVID who have trouble exercising and feel very tired after activity. Researchers will test if these treatments can improve how long patients can walk and their overall quality of life. About 360 adults with Long C…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 16, 2026 12:48 UTC
-
Could a Weight-Loss drug protect your brain? new study investigates
Knowledge-focused TerminatedThis study looks at whether liraglutide (Saxenda®), a weight-loss medication, can increase a protein called BDNF that helps protect the brain. It involves 30 adults with multiple sclerosis, long-COVID, or leukemia in remission who also have obesity and memory or thinking issues. …
Matched conditions: LONG COVID19
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:06 UTC